Mobile

Study of MK-1986 (tedizolid phosphate) in children 3 mo to <12 yr with acute bacterial skin and skin structure infections (ABSSSI)

Mise à jour : Il y a 4 ans
Référence : EUCTR2016-003884-20

Femme et Homme

  • | Pays :
    • -
  • | Organes :
    • -
  • | Spécialités :
    • -

Extrait

(1) The primary objective is to use descriptive statistics to evaluate the safety of intravenous (IV) and/or oral 6- or 10-day tedizolid phosphate with 10- or 14-day IV and/or oral comparator in subjects 3 months to <12 years of age with acute bacterial skin and skin structure infections (ABSSSI). No formal hypothesis tests will be used to evaluate this endpoint.

Critère d'inclusion

  • acute bacterial skin and skin structure infections (abSSSI)

Liens